Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Clinical trials have shown significant weight loss in participants using semaglutide (15-20% in some cases), compared to other weight loss medications or lifestyle changes alone
NICE Clinical Knowledge Summary
Continue reading to learn more about these treatments
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Description Bacteriostatic Water (30ml) for Laboratory Research Notice: This product is intended for scientific research, analytical, and laboratory applications only
US$ 24.35
US$ 25.90
US$ 20.75
US$ 28.35
US$ 23.66
US$ 28.01
US$ 22.68
